Fabrication of Hyaluronic Acid Surface Modified Solid Lipid Nanoparticles Loaded with Imatinib Mesylate for Targeting Human Breast Cancer MCF-7 Cells

This publication has 16 references indexed in Scilit:

• Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
  Cancer Letters, 2013
• Identification of Breast Cancer Prognosis Markers Using Integrative Sparse Boosting
  Methods of Information in Medicine, 2012
• Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
  Advanced Drug Delivery Reviews, 2011
• Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel
  International Journal of Pharmaceutics, 2011
• Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
  European Journal of Pharmaceutics and Biopharmaceutics, 2009
• Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2008
• Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
  Advanced Drug Delivery Reviews, 2007
• Solid lipid nanoparticles for parenteral drug delivery
  Advanced Drug Delivery Reviews, 2004
• Targeting Lymphatic Metastasis
  Science, 2002
• Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art
  European Journal of Pharmaceutics and Biopharmaceutics, 2000